Ahmed Elsharkawy/LinkedIn
Sep 23, 2026, 00:02
Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
Ahmed Elsharkawy, ICU and Oncology Clinical Pharmacist at Children’s Cancer Hospital Foundation 57357, shared a post on LinkedIn:
“One of the major roles of Clinical pharmacist is to check Drug-Drug and Drug-Diluent incompatibilities especially for patients in ICUs and hematology units as they are considered a high-risk group for the occurrence of incompatibilities because they commonly require the use of multiple drugs, most of which are administered intravenously and by continuous infusion.
Potential complications of co-administration of incompatible drugs include:
- Precipitation
- Central venous catheter (CVC) occlusion or malfunction
- Reduced potency of medication
- Embolism and local or systemic inflammatory reactions.”

Stay updated with Hemostasis Today.
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency